{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-031985","form_type":"8-K","ticker":"TARA","cik":"0001359931","company_name":"Protara Therapeutics, Inc.","filed_at":"2022-06-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.364242+00:00","generated_at":"2026-06-25T03:05:52.018381+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Protara Therapeutics shareholders elect three directors, ratify auditor, approve say-on-pay at 2022 annual meeting","bullets":["Elected Luke Beshar, Roger Garceau, and Gregory Sargen as Class II directors to serve until 2025 annual meeting.","Ratified Ernst & Young as independent registered public accounting firm for fiscal year ending Dec 31, 2022 with 8,385,650 votes for.","Advisory vote approved compensation of named executive officers with 6,426,881 votes for, 126,276 against, 54,902 abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-031985","json":"https://secwatch.observer/filing/0001213900-22-031985.json","markdown":"https://secwatch.observer/filing/0001213900-22-031985.md","text":"https://secwatch.observer/filing/0001213900-22-031985.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1359931/000121390022031985/0001213900-22-031985-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1359931/000121390022031985/ea161338-8k_protara.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T03:05:52.018381+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}